Germany Pharmaceuticals & Healthcare Report Q2 2014 - New Market Research Report
The downward pressure on generic medicine prices, as a result of tenders raising the level of competition and the ultimate commoditisation of off-patent medicines, draws attention to the inherent challenges for generic drugmakers looking to profit from the government's focus on cost containment in the healthcare sector. The German pharmaceutical market used to be dominated by branded medicines and reasonable profit could be realised. However, over the past few years, the government has sought to contain healthcare costs in light...
View full press release